Fritextsökning
Innehållstyper
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Nanotechforskare får proof of concept-bidrag
Winnie E. Svendsen är en av sex forskare vid Danmarks Tekniska Universitet, DTU, som får dela på 5,4 miljoner svenska kronor från the Proof-of-Concept Fund.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Unika labb får miljonanslag
203 miljoner kronor har fördelats på ett flertal svenska labb.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
"Det kommer nog ingen andra våg av covid-19"
Det är dags att sluta se på det nya coronaviruset som om det vore en influensa. Life Science Sweden har intervjuat infektionsprofessorn Björn Olsen om flockimmu...
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Vill satsa på skräddarsydd medicin
USA:s president startar ett initiativ för personalized medicine.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Hennes tweet sänker börsen
Hillary Clinton föreslår nya tag mot skenande läkemedelspriser.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Recipharm kammar hem entreprenörtitel
Lars Backsell och Thomas Eldered representerar Stockholm i Sverigefinalen.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
BREAKING